Cardinal Health
12
1
1
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
25.0%
3 terminated/withdrawn out of 12 trials
70.0%
-16.5% vs industry average
17%
2 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Real-world Study of First Line Pembrolizumab- or Nivolumab-treated HPV-positive Recurrent/Metastatic Oropharyngeal Squamous Cell Carcinoma
Role: collaborator
Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer
Role: collaborator
Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection
Role: collaborator
Design Validation Hemodynamic Study of New Kendall SCD SmartFlow Compression System
Role: lead
Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device
Role: collaborator
Incidence and Relationship of Positive Preoperative Methicillin Resistant Staphylococcus Aureus (MRSA) Screens and Post-operative Infections
Role: collaborator
The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Venous Access-Site Closure
Role: collaborator
Negating Opioid and Pain Actively Through Intervention
Role: collaborator
Pilot Study Comparing the Efficacy and Safety of a New Pain Patch and Placebo in Delayed Onset Muscle Soreness (DOMS)
Role: collaborator
Simple Suppers Scale-up (S3)
Role: collaborator
Cost Effectiveness and Efficacy of Kyphoplasty and Vertebroplasty Trial
Role: collaborator
Medication Histories Conducted by Nurses (RNs), Pharmacy Techs (CPhTs) & Pharmacists (RPhs)
Role: collaborator
All 12 trials loaded